Home › PGEL › Filing
🔔 Get instant alerts when PGEL files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 27 Oct 2026, 19:31 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - 2Q FY2027 - Consolidated Q2 sales grew 42.5% y-y to INR 933.88 Cr; H1 sales up 37.4% to INR 2967.83 Cr - EBITDA margin improved to 7.4% in Q2 and 7.6% in H1 FY27 - Net income rose 395.2% y-y in Q2 to INR 13.67 Cr and 28.9% in H1 to INR 89.88 Cr - Expansion projects on track; new washing machine plant with 1.8 mn units capacity to start in Q4 FY27 - Raw material cost increases fully passed to customers; focus on expense control and capital efficiency - Management optimistic on growth driven by consumer durables and plastic moulding segments - Industry outlook positive with government reforms and rising middle class demand - Strategic priorities include R&D, backward integration, and capability enhancement
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PGEL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PGEL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on PG Electroplast Limited

Important. The summary above is generated automatically from PG Electroplast Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.